All-trans retinoic acid and gemtuzumab ozogamicin as adjunct to high-dose cytarabine-based salvage therapy in primary refractory acute myeloid leukemia: Results of AMLSG 05-04 trial

Document type:: Meeting Abstract
Author(s):: Schlenk, RF; Döhner, K; Krauter, J; Späth, D; De Valle, F; Heydrich, B; Horst, HA; Schmidt-Wolf, I; Rummel, M; Götze, K; Koller, E; Petzer, A; Mergenthaler, HG; Salwender, H; Fiedler, W; Kirchen, H; Haase, D; Kramers, S; Theobald, M; Matzdorff, AC; Ganser, A; Duhner, H
Title:: All-trans retinoic acid and gemtuzumab ozogamicin as adjunct to high-dose cytarabine-based salvage therapy in primary refractory acute myeloid leukemia: Results of AMLSG 05-04 trial
Journal title abbreviation:: Blood
Year:: 2007
Journal volume:: 110
Journal issue:: 11
Pages contribution:: 544A-544A
Language:: eng
Print-ISSN:: 0006-4971
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: